182 related articles for article (PubMed ID: 26753694)
1. Favorable prognostic influence of T-box transcription factor Eomesodermin in metastatic renal cell cancer patients.
Dielmann A; Letsch A; Nonnenmacher A; Miller K; Keilholz U; Busse A
Cancer Immunol Immunother; 2016 Feb; 65(2):181-92. PubMed ID: 26753694
[TBL] [Abstract][Full Text] [Related]
2. Systemic immune tuning in renal cell carcinoma: favorable prognostic impact of TGF-β1 mRNA expression in peripheral blood mononuclear cells.
Busse A; Asemissen A; Nonnenmacher A; Ochsenreither S; Fusi A; Braun F; Stather D; Schmittel A; Miller K; Thiel E; Keilholz U
J Immunother; 2011 Jan; 34(1):113-9. PubMed ID: 21150720
[TBL] [Abstract][Full Text] [Related]
3. Characterization of eomesodermin and T-bet expression by allostimulated CD8
Perez-Gutierrez A; Metes DM; Lu L; Hariharan S; Thomson AW; Ezzelarab MB
Clin Exp Immunol; 2018 Nov; 194(2):259-272. PubMed ID: 30246373
[TBL] [Abstract][Full Text] [Related]
4. Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver.
Harmon C; Robinson MW; Fahey R; Whelan S; Houlihan DD; Geoghegan J; O'Farrelly C
Eur J Immunol; 2016 Sep; 46(9):2111-20. PubMed ID: 27485474
[TBL] [Abstract][Full Text] [Related]
5. Technical Advance: Fluorescent reporter reveals insights into eomesodermin biology in cytotoxic lymphocytes.
Paley MA; Gordon SM; Bikoff EK; Robertson EJ; Wherry EJ; Reiner SL
J Leukoc Biol; 2013 Feb; 93(2):307-15. PubMed ID: 23192430
[TBL] [Abstract][Full Text] [Related]
6. HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients.
Wang J; Liu L; Qu Y; Xi W; Xia Y; Bai Q; Xiong Y; Long Q; Xu J; Guo J
Cancer Immunol Immunother; 2018 Jan; 67(1):79-87. PubMed ID: 28918459
[TBL] [Abstract][Full Text] [Related]
7. Cutting Edge: Eomesodermin Is Sufficient To Direct Type 1 Innate Lymphocyte Development into the Conventional NK Lineage.
Pikovskaya O; Chaix J; Rothman NJ; Collins A; Chen YH; Scipioni AM; Vivier E; Reiner SL
J Immunol; 2016 Feb; 196(4):1449-54. PubMed ID: 26792802
[TBL] [Abstract][Full Text] [Related]
8. Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues.
Ning XH; Gong YQ; He SM; Li T; Wang JY; Peng SH; Chen JC; Liu JY; Qi NN; Guo YL; Gong K
Oncotarget; 2017 Jan; 8(2):3355-3363. PubMed ID: 27926518
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis on the efficacy of sunitinib/sorafenib in combination with dendritic cells-cytokine-induced killer in metastasis renal cell carcinoma after radical nephrectomy.
Mai HX; Mei GH; Zhao FL; Li BT; Tang YY; Zhang B; Xu XJ; Chen LJ
J Cancer Res Ther; 2018 Jun; 14(Supplement):S427-S432. PubMed ID: 29970701
[TBL] [Abstract][Full Text] [Related]
10. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
Viey E; Fromont G; Escudier B; Morel Y; Da Rocha S; Chouaib S; Caignard A
J Immunol; 2005 Feb; 174(3):1338-47. PubMed ID: 15661891
[TBL] [Abstract][Full Text] [Related]
11. NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin.
Simonetta F; Pradier A; Bosshard C; Masouridi-Levrat S; Chalandon Y; Roosnek E
J Immunol; 2015 Nov; 195(10):4712-20. PubMed ID: 26438526
[TBL] [Abstract][Full Text] [Related]
12. [Expression of natural killer cell development-associated transcription factors in nasal NK/T-cell lymphomas occurring in Chinese population].
Zhang S; Nong L; Zhang Y; Wang Y; Li T
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):366-71. PubMed ID: 21055151
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
[TBL] [Abstract][Full Text] [Related]
14. Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells.
Tayade C; Fang Y; Black GP; V A P; Erlebacher A; Croy BA
J Leukoc Biol; 2005 Dec; 78(6):1347-55. PubMed ID: 16204645
[TBL] [Abstract][Full Text] [Related]
15. Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma.
Furuya N; Kamai T; Shirataki H; Yanai Y; Fukuda T; Mizuno T; Nakamura F; Kambara T; Nakanishi K; Abe H; Yoshida K
Cancer Immunol Immunother; 2011 Jun; 60(6):793-808. PubMed ID: 21350947
[TBL] [Abstract][Full Text] [Related]
16. T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells.
Kiekens L; Van Loocke W; Taveirne S; Wahlen S; Persyn E; Van Ammel E; De Vos Z; Matthys P; Van Nieuwerburgh F; Taghon T; Van Vlierberghe P; Vandekerckhove B; Leclercq G
Front Immunol; 2021; 12():732511. PubMed ID: 34630413
[TBL] [Abstract][Full Text] [Related]
17. Expression of PBRM1 as a prognostic predictor in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitor.
Cai W; Wang Z; Cai B; Yuan Y; Kong W; Zhang J; Chen Y; Liu Q; Huang Y; Huang J; Xue W
Int J Clin Oncol; 2020 Feb; 25(2):338-346. PubMed ID: 31720994
[TBL] [Abstract][Full Text] [Related]
18. Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging.
Eckl J; Buchner A; Prinz PU; Riesenberg R; Siegert SI; Kammerer R; Nelson PJ; Noessner E
J Mol Med (Berl); 2012 Jan; 90(1):55-66. PubMed ID: 21870102
[TBL] [Abstract][Full Text] [Related]
19. [Role of transcription factor T-bet and Eomes in IFN-gamma secretion of different human T cell subsets].
Wang HT; Ge XS; Xue ZP; Li BQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jan; 26(1):31-4. PubMed ID: 20056084
[TBL] [Abstract][Full Text] [Related]
20. Differential localization of T-bet and Eomes in CD8 T cell memory populations.
McLane LM; Banerjee PP; Cosma GL; Makedonas G; Wherry EJ; Orange JS; Betts MR
J Immunol; 2013 Apr; 190(7):3207-15. PubMed ID: 23455505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
